Quantum Biopharma (QNTM) Accumulated Depreciation & Amortization (2019 - 2022)

Quantum Biopharma's Accumulated Depreciation & Amortization history runs 4 years deep, the most recent figure standing at $4.5 million for Q4 2022.

• In Q4 2022, Accumulated Depreciation & Amortization rose 12.16% year-over-year to $4.5 million; the TTM figure through Dec 2022 stood at $4.5 million (up 12.16% YoY), while the FY2022 annual figure was $4.5 million, up 12.16% from the prior year.
• Accumulated Depreciation & Amortization came in at $4.5 million for Q4 2022 at Quantum Biopharma, up from $4.0 million in the prior quarter.
• In the past five years, Accumulated Depreciation & Amortization ranged from a high of $4.5 million in Q4 2022 to a low of $1.9 million in Q4 2019.
• A 4-year average of $3.6 million and a median of $4.0 million in 2020 frame the typical range for Accumulated Depreciation & Amortization.
• Across the five-year window, Accumulated Depreciation & Amortization surged 100.74% in 2020 and increased 3.72% in 2021, its largest moves.
• Quantum Biopharma's Accumulated Depreciation & Amortization stood at $1.9 million in 2019, then soared by 100.74% to $3.9 million in 2020, then climbed by 3.72% to $4.0 million in 2021, then climbed by 12.16% to $4.5 million in 2022.
• According to Business Quant data, Accumulated Depreciation & Amortization over the past three periods registered $4.5 million, $4.0 million, and $3.9 million for Q4 2022, Q4 2021, and Q4 2020 respectively.

Peer Comparison